NX Pharmagen

Louisville, United States

NX PharmaGen acquires, develops, and monetizes mature clinical-stage breakthrough technologies.

$590K raised

Oct 2022

Debt Financing

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has NX Pharmagen raised?

NX Pharmagen has raised $590K in total funding. The most recent round was Debt Financing. The last funding was announced in October 2022.

Who are NX Pharmagen's investors?

NX Pharmagen's investors include Keyhorse Capital.

Where is NX Pharmagen headquartered?

NX Pharmagen is headquartered in Louisville, United States.

What does NX Pharmagen do?

NX PharmaGen acquires, develops, and monetizes mature clinical-stage breakthrough technologies.

What stage is NX Pharmagen at?

NX Pharmagen is at the Debt Financing stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated October 21, 2022.

MLA

"NX Pharmagen — Funding & Investors." VCBacked, October 21, 2022, https://www.vcbacked.co/company/nx-pharmagen. Accessed July 2, 2026.

APA

VCBacked. (2022). NX Pharmagen — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nx-pharmagen

Wikipedia (cite web)

{{cite web |title=NX Pharmagen — Funding & Investors |url=https://www.vcbacked.co/company/nx-pharmagen |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated October 21, 2022.